RepliCel Life Sciences

Vancouver, Canada

RepliCel Life Sciences is a regenerative medicine company using cell therapy products for healing tendinosis, aging, and pattern baldness.

$224K raised

Dec 2024

Post-IPO Equity

Biotechnology Health Care Therapeutics

Top Investors

YOFOTO MainPointe Pharmaceuticals

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about RepliCel Life Sciences

How much funding has RepliCel Life Sciences raised?

RepliCel Life Sciences has raised $224K in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2024.

Who are RepliCel Life Sciences's investors?

RepliCel Life Sciences's investors include YOFOTO, MainPointe Pharmaceuticals.

Where is RepliCel Life Sciences headquartered?

RepliCel Life Sciences is headquartered in Vancouver, Canada.

What does RepliCel Life Sciences do?

RepliCel Life Sciences is a regenerative medicine company using cell therapy products for healing tendinosis, aging, and pattern baldness.

What stage is RepliCel Life Sciences at?

RepliCel Life Sciences is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 16, 2024.

MLA

"RepliCel Life Sciences — Funding & Investors." VCBacked, December 16, 2024, https://www.vcbacked.co/company/replicel-life-sciences. Accessed July 3, 2026.

APA

VCBacked. (2024). RepliCel Life Sciences — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/replicel-life-sciences

Wikipedia (cite web)

{{cite web |title=RepliCel Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/replicel-life-sciences |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 16, 2024.